ZINDACLIN

This brand name is authorized in Austria, Hong Kong SAR China, Ireland, Israel, Singapore, Spain, Turkey, UK.

Active ingredients

The drug ZINDACLIN contains one active pharmaceutical ingredient (API):

1	Clindamycin UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE
	Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.
	Read more about Clindamycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZINDACLIN Gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AF01	Clindamycin	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	66610
GB	Medicines & Healthcare Products Regulatory Agency	38170
HK	Department of Health Drug Office	53655
IE	Health Products Regulatory Authority	59816
IL	מִשְׂרַד הַבְּרִיאוּת	4695
SG	Health Sciences Authority	13157P
TR	İlaç ve Tıbbi Cihaz Kurumu	8697757341016